36
Views
0
CrossRef citations to date
0
Altmetric
Reports

Ferroptosis as a biological Phase transition II: Chronotherapy of avascular and vascular tumor growth

, , &
Pages 722-731 | Received 04 Mar 2023, Accepted 02 Sep 2023, Published online: 13 Sep 2023

References

  • Agmon E, Solon J, Bassereau P, Stockwell BR. 2018. Modeling the effects of lipid peroxidation during ferroptosis on membrane properties. Sci Rep. 8(1):5155. doi: 10.1038/s41598-018-23408-0.
  • Amiama-Roig A, Verdugo-Sivianes EM, Carnero A, Blanco JR. 2022. Chronotherapy: circadian rhythms and their influence in cancer therapy. Cancers. 14(20):5071. doi: 10.3390/cancers14205071.
  • Andronov AA, Chaikin CE, Khaĭkin SĖ, Khaikin SE. 1949. Theory of oscillations. Princeton, Nueva Jersey: Princeton University Press.
  • Axelrod DE. 2022. Chronotherapy of early colon cancer: advantage of morning dose schedules. Cancer Inform. 21:11769351211067697. doi:10.1177/11769351211067697.
  • Baier G, Sahle S. 1994. Hyperchaos and chaotic hierarchy in low‐dimensional chemical systems. J Chem Phys. 100(12):8907–8911. doi: 10.1063/1.466694.
  • Betancourt-Mar JA, Alarcón-Montelongo IS, Nieto-Villar JM. 2005. The Rössler system as a model for chronotherapy. J Phys Conf Ser. 23(1):58–61. doi: 10.1088/1742-6596/23/1/006.
  • Betancourt-Mar JA, Alarcón-Montelongo IS, Nieto-Villar JM. 2006. Theoretical models in chronotherapy: II. Periodic perturbations in a chaotic chemical reaction. Biol Rhythm Res. 37(2):131–136. doi: 10.1080/09291010500332083.
  • Betancourt-Mar JA, Llanos-Pérez JA, Cocho G, Mansilla R, Martin RR, Montero S, Nieto-Villar JM. 2017. Phase transitions in tumor growth: IV relationship between metabolic rate and fractal dimension of human tumor cells. Physica A. 473:344–351. doi:10.1016/j.physa.2016.12.089.
  • Betancourt-Mar JA, Méndez-Guerrero VA, Hernández-Rodríguez C, Nieto Villar JM. 2010. Theoretical models for chronotherapy: periodic perturbations in hyperchaos. Math Biosci Eng. 7(3). doi: 10.3934/mbe.2010.7.553.
  • Betancourt-Mar J, Nieto-Villar J. 2007. Theoretical models for chronotherapy: periodic perturbations in funnel chaos type. Math Biosci Eng. 4(2):177.
  • Betancourt-Padron PJ, García-Medina K, Mansilla R, Nieto-Villar JM. 2020. Phase transition in tumor growth VIII: the spatiotemporal of avascular evolution. Revista Mexicana de Física. 66(6 Nov–Dec):856–862. doi: 10.31349/RevMexFis.66.856.
  • Boccaletti S, Grebogi C, Lai YC, Mancini H, Maza D. 2000. The control of chaos: theory and applications. Phys Rep. 329(3):103–197. doi: 10.1016/S0370-1573(99)00096-4.
  • Chen X, Kang R, Kroemer G, Tang D. 2021. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 18(5):280–296. doi: 10.1038/s41571-020-00462-0.
  • Chen P, Li X, Zhang R, Liu S, Xiang Y, Zhang M, Chen X, Pan T, Yan L, Feng J. 2020. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics. 10(11):5107. doi: 10.7150/thno.44705.
  • Choudhary JP, Sahu T, Pande B. 2022. Molecular underpinnings of circadian mechanism, chronotherapy and lung cancer: a mini-review. Polymorphism. 8:13–25.
  • Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Stockwell BR, Bauer A, Cantley A, Yang W. 2012. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 149(5):1060–1072. doi: 10.1016/j.cell.2012.03.042.
  • Guerra A, Rodríguez DJ, Montero S, Betancourt-Mar JA, Martin RR, Silva E, Bizzarri JM, Cocho G, Mansilla R, Nieto-Villar JM. 2018. Phase transitions in tumor growth VI: epithelial–mesenchymal transition. Physica A. 499:208–215. doi:10.1016/j.physa.2018.01.040.
  • Guerra A, Rodríguez DJ, Silva E, Betancourt-Mar JA, Cocho G, Nieto-Villar RMJM, Mansilla R. 2019. Chronotherapy of cancer: Epithelial-Mesenchymal transition. MOJ Gerontol Ger. 4(4):124–127. doi: 10.15406/mojgg.2019.04.00192.
  • Hong T, Lei G, Chen X, Li H, Zhang X, Wu N, Zhao J, Zhang Y, Wang J. 2021. PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer. Redox Biol. 42:101928. doi:10.1016/j.redox.2021.101928.
  • Hoops S, Lee R, Gauges C, Simus J, Pahle N, Xu M, Singhal L, Kummer P, Mendes U, Kummer U. 2006. COPASI—a COmplex PAthway SImulator. Bioinformatics. 22(24):3067–3074. doi: 10.1093/bioinformatics/btl485.
  • Izquierdo-Kulich E, Rebelo I, Tejera E, Nieto-Villar JM. 2013. Phase transition in tumor growth: I avascular development. Physica A. 392(24):6616–6623. doi: 10.1016/j.physa.2013.08.010.
  • Jaime JC, Mesa-Álvarez MD, Martin RR, Betancourt-Mar JA, Cocho G, Mansilla R, Nieto-Villar JM. 2019. Chronotherapy of cancer: periodic perturbations in vascular growth and metastasis. Biol Rhythm Res. 50(4):495–504. doi: 10.1080/09291016.2018.1465698.
  • Kitano H. 2007. Towards a theory of biological robustness. Mol Syst Biol. 3(1):137. doi: 10.1038/msb4100179.
  • Kuznetsov YA. 2013. Elements of applied bifurcation theory. New York: Springer Science & Business Media.
  • Lei G, Zhuang L, Gan B. 2022. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 22(7):381–396. doi: 10.1038/s41568-022-00459-0.
  • Lévi F. 2001. Circadian chronotherapy for human cancers. Lancet Oncol. 2(5):307–315. doi: 10.1016/S1470-2045(00)00326-0.
  • Llanos-Pérez JA, Betancourt-Mar JA, Cocho G, Mansilla R, Nieto-Villar JM. 2016. Phase transitions in tumor growth: III vascular and metastasis behaviour. Physica A. 462:560–568. doi:10.1016/j.physa.2016.06.086.
  • Llanos-Pérez JA, Betancourt-Mar A, De Miguel MP, Izquierdo-Kulich E, Royuela-García M, Tejera E, Nieto-Villar JM. 2015. Phase transitions in tumor growth: II prostate cancer cell lines. Physica A. 426:88–92. doi:10.1016/j.physa.2015.01.038.
  • Majeed H, Gupta V. 2022. Adverse effects of radiation therapy. In: StatPearls [internet]. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK563259/.
  • Martin RR, Montero S, Silva E, Bizzarri M, Cocho G, Mansilla R, Nieto- Villar JM. 2017. Phase transitions in tumor growth: V what can be expected from cancer glycolytic oscillations? Physica A. 486:762–771. doi:10.1016/j.physa.2017.06.001.
  • Montero S, Martin R, Mansilla R, Cocho G, Nieto-Villar JM. 2018. Parameters estimation in phase-space landscape reconstruction of cell fate: a systems biology approach. Syst Biol (Stevenage). 1702:125–170. doi:10.1007/978-1-4939-7456-6_8.
  • Mormont MC, Lévi F. 2003. Cancer chronotherapy: principles, applications, and perspectives. Cancer: Interdisciplinary Int J American Cancer Soc. 97(1):155–169. doi: 10.1002/cncr.11040.
  • Nieto-Villar JM, Mansilla R. 2021. Ferroptosis as a biological Phase transition I: avascular and vascular tumor growth. Eur J Biomed Pharm Sci. 8(12):63–70.
  • Pikovsky A, Rosenblum M, Kurths J, Hilborn RC. 2002. Synchronization: a universal concept in nonlinear science. Am J Phys. 70(6):655–655. doi: 10.1119/1.1475332.
  • Pomuceno-Orduñez JP, Silva E, Martin RR, Durán I, Bizzarri M, Cocho G, Mansilla R, Nieto-Villar JM. 2019. Phase transitions in tumor growth VII: the effect of periodic glucose pulses and privations in a cancer model. Integr Cancer Sci Therap. 6(1): doi: 10.15761/ICST.1000301.
  • Roose T, Chapman SJ, Maini PK. 2007. Mathematical models of avascular cancer. Siam Rev. 49(2):179–208. doi: 10.1137/S0036144504446291.
  • Rössler OE. 1976. An equation for continuous chaos. Phys Lett A. 57(5):397–398. doi: 10.1016/0375-9601(76)90101-8.
  • Salazar C, Garcia L, Rodriguez Y, Garcia JM, Quintana R, Rieumont J, Nieto-Villar JM. 2003. Theoretical models of chronotherapy: I. Periodic perturbations in oscillating chemical reactions. Biol Rhythm Res. 34(3):241–249. doi: 10.1076/brhm.34.3.241.18813.
  • Schirrmacher V. 2019. From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment. Int J Oncol. 54(2):407–419. doi: 10.3892/ijo.2018.4661.
  • Shafer DS. 1995. Nonlinear dynamics and chaos: with applications to physics, biology, chemistry, and engineering (Steven H. Strogatz). Siam Rev. 37(2):280–281. doi: 10.1137/1037077.
  • Silva E, Martin RR, Pomuceno JP, Mansilla R, Betancourt-Mar JA, Cocho G, Nieto-Villar JM. 2019. Dose and frequency in cancer therapy. Theoretical non-autonomous model of p53 network. Biol Rhythm Res. 50(3):483–489. doi: 10.1080/09291016.2018.1465697.
  • Song X, Wang X, Liu Z, Yu Z. 2020. Role of GPX4-mediated ferroptosis in the sensitivity of triple-negative breast cancer cells to gefitinib. Front Oncol. 10:597434. doi:10.3389/fonc.2020.597434.
  • Wolf A, Swift JB, Swinney HL, Vastano JA. 1985. Determining Lyapunov exponents from a time series. Physica D. 16(3):285–317. doi: 10.1016/0167-2789(85)90011-9.
  • Zhang C, Liu X, Jin S, Chen Y, Guo R. 2022. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 21(1):47. doi: 10.1186/s12943-022-01530-y.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.